INDEMNIFICATION AGREEMENTIndemnification Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of November 15, 2012 between Applied Genetic Technologies Corporation, a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).
ContractApplied Genetic Technologies Corp • January 10th, 2014 • Biological products, (no disgnostic substances) • California
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AND PURSUANT TO THE PROVISIONS OF ARTICLE 5 BELOW, MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAW OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER. PLEDGE OR HYPOTHECATION IS EXEMPT FROM REGISTRATION.
ContractApplied Genetic Technologies Corp • January 10th, 2014 • Biological products, (no disgnostic substances) • North Carolina
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAW.
APPLIED GENETIC TECHNOLOGIES CORPORATION AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT NOVEMBER 15, 2012Investor Rights Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is entered into as of the 15th day of November, 2012, by and among APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation (the “Company”) and the investors listed on Exhibit A (referred to hereinafter as the “Investors” and each individually as an “Investor”) and the stockholders listed on Exhibit B hereto (the “Common Stockholders”).
APPLIED GENETIC TECHNOLOGIES CORPORATION WARRANT TO PURCHASE SHARESApplied Genetic Technologies Corp • January 10th, 2014 • Biological products, (no disgnostic substances) • Florida
THIS WARRANT is issued to [ ] (the “Holder”) by APPLIED GENETIC TECHNOLOGIES CORPORATION, a Delaware corporation (the “Company”), pursuant to the terms of that certain Subscription Agreement dated [ ], in connection with the Company’s issuance to the holder of this Warrant of a Convertible Promissory Note (the “Note”).
STANDARD EXCLUSIVE LICENSE AGREEMENT WITH KNOW HOW - Agreement No: A11361 PROMOTER TECHNOLOGY LICENSEStandard Exclusive License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Agreement is made effective the 18th day of September, 2012, (the “Effective Date”) by and between the University of Florida Research Foundation, Inc. (hereinafter called “UFRF”), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation (hereinafter called “Licensee”), a small entity corporation organized and existing under the laws of Delaware;
NON-EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSNon-Exclusive License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Agreement is made effective the 19th day of January 2006 (hereinafter “Effective Date”) by and between The UAB Research Foundation (hereinafter “UABRF”), a nonstock, nonprofit Alabama corporation having an office at 701 20th Street South, Birmingham, AL 35294 USA and AGTC (hereinafter “Licensee”), a corporation organized and existing under the laws of Delaware and having a principal office at 12085 Research Drive, Alachua, Florida 32615.
ContractApplied Genetic Technologies Corp • January 10th, 2014 • Biological products, (no disgnostic substances) • North Carolina
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAW.
STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSExclusive License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This Agreement is made effective the 7th day of October, 2003, (the “Effective Date”) by and between the University of Florida Research Foundation, Inc. (hereinafter called “UFRF”), a nonstock, nonprofit Florida corporation, Johns Hopkins University (hereinafter “JHU”), a Maryland Corporation, and Applied Genetic Technologies, Inc. and any Affiliates of Applied Genetic Technologies, Inc. (hereinafter called “Licensee”), a corporation organized and existing under the laws of Florida;
RESTATED AMENDMENT TO LICENSE AGREEMENT (B)License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • Florida
This Restated Amendment to License Agreement (this “Restated Amendment”) is made and effective as of January 31, 2005 (“Effective Date”), by and between the University of Florida Research Foundation, Inc. (“UFRF”), a nonstock, nonprofit Florida corporation, and Applied Genetic Technologies Corporation (“Licensee”), a corporation organized and existing under the laws of the State of Delaware.
FIRST AMENDMENT RESTATED AMENDMENT TO LICENSE AGREEMENT (B) (A2124)License Agreement • January 10th, 2014 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances)
This First Amendment after Restated Amendment to License Agreement (this “First Amendment after Restated Amendment”) is made and effective as of November, 28 2007 by and between the University of Florida Research Foundation, Inc (“UFRF”) a non-stock, non-profit Florida corporation and Applied Genetic Technologies Corporation (“Licensee”) a corporation organized and existing under the laws of the State of Delaware.
